Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
Jean‐Philippe Krieger, Myrtha Arnold, Klaus G. Pettersen, et al.
Diabetes (2015) Vol. 65, Iss. 1, pp. 34-43
Open Access | Times Cited: 221

Showing 26-50 of 221 citing articles:

Signalling from the periphery to the brain that regulates energy homeostasis
Ki‐Suk Kim, Randy J. Seeley, Darleen A. Sandoval
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 4, pp. 185-196
Open Access | Times Cited: 152
GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose
Yusaku Iwasaki, Sendo Mio, Katsuya Dezaki, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 148
Semaglutide as a promising antiobesity drug
Georgios A. Christou, Niki Katsiki, John E. Blundell, et al.
Obesity Reviews (2019) Vol. 20, Iss. 6, pp. 805-815
Closed Access | Times Cited: 124
Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor–Expressing Glutamatergic Neurons
Jessica M. Adams, Hongjuan Pei, Darleen A. Sandoval, et al.
Diabetes (2018) Vol. 67, Iss. 8, pp. 1538-1548
Open Access | Times Cited: 120
Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
Giovanna Muscogiuri, Ralph A. DeFronzo, Amalia Gastaldelli, et al.
Trends in Endocrinology and Metabolism (2016) Vol. 28, Iss. 2, pp. 88-103
Closed Access | Times Cited: 119
Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight
Ronald P. Gaykema, Brandon A. Newmyer, Matteo Ottolini, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 3, pp. 1031-1045
Open Access | Times Cited: 111
Microbiota‐gut‐brain axis as a regulator of reward processes
Rubén García‐Cabrerizo, Carina Carbia, Kenneth J. O ́Riordan, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 5, pp. 1495-1524
Closed Access | Times Cited: 106
The metabolic role of vagal afferent innervation
T.M. Zaved Waise, Helen J. Dranse, Tony K.T. Lam
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 10, pp. 625-636
Closed Access | Times Cited: 103
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Darren Riddy, Philippe Delerive, Roger J. Summers, et al.
Pharmacological Reviews (2017) Vol. 70, Iss. 1, pp. 39-67
Open Access | Times Cited: 102
Small talk: microbial metabolites involved in the signaling from microbiota to brain
Giorgia Caspani, Jonathan R. Swann
Current Opinion in Pharmacology (2019) Vol. 48, pp. 99-106
Closed Access | Times Cited: 100
The physiological control of eating: signals, neurons, and networks
Alan G. Watts, Scott E. Kanoski, Graciela Sanchez‐Watts, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 689-813
Open Access | Times Cited: 99
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
Kenichi Katsurada, Toshihiko Yada
Journal of Diabetes Investigation (2016) Vol. 7, Iss. S1, pp. 64-69
Open Access | Times Cited: 95
Do we know the true mechanism of action of the DPP‐4 inhibitors?
Emilie S. Andersen, Carolyn F. Deacon, Jens J. Holst
Diabetes Obesity and Metabolism (2017) Vol. 20, Iss. 1, pp. 34-41
Closed Access | Times Cited: 95
GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats
Samantha M. Fortin, Rachele K. Lipsky, Rinzin Lhamo, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 533
Open Access | Times Cited: 94
Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity
Philip Prinz, Andreas Stengel
Journal of Neurogastroenterology and Motility (2017) Vol. 23, Iss. 2, pp. 180-196
Open Access | Times Cited: 90
A Role for GLP-1 in Treating Hyperphagia and Obesity
Harvey J. Grill
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 85
Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action
Elodie M. Varin, Erin E. Mulvihill, Laurie L. Baggio, et al.
Cell Reports (2019) Vol. 27, Iss. 11, pp. 3371-3384.e3
Open Access | Times Cited: 83
The hypothalamus for whole-body physiology: from metabolism to aging
Tiemin Liu, Yong Xu, Chun‐Xia Yi, et al.
Protein & Cell (2021) Vol. 13, Iss. 6, pp. 394-421
Open Access | Times Cited: 77
Regulation of body weight: Lessons learned from bariatric surgery
Vance L. Albaugh, Yanlin He, Heike Münzberg, et al.
Molecular Metabolism (2022) Vol. 68, pp. 101517-101517
Open Access | Times Cited: 48
Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids
Shixu Wang, Chongchong Xu, Hongyan Liu, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4618-4640
Closed Access | Times Cited: 22
Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function
Wenran Ren, Jianhui Chen, Wenjing Wang, et al.
Neuron (2024) Vol. 112, Iss. 6, pp. 972-990.e8
Open Access | Times Cited: 10
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Simon Hoffman, Khosrow Adeli
Medical Review (2024) Vol. 4, Iss. 4, pp. 301-311
Open Access | Times Cited: 8
A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK)
C. Mary Schooling, Guoyi Yang, Ghada A. Soliman, et al.
Life (2025) Vol. 15, Iss. 2, pp. 253-253
Open Access | Times Cited: 1
The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes
Merlin C. Thomas
Diabetes & Metabolism (2017) Vol. 43, pp. 2S20-2S27
Closed Access | Times Cited: 85
Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control
Amber L. Alhadeff, Blake Mergler, Derek J. Zimmer, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 7, pp. 1471-1479
Open Access | Times Cited: 78

Scroll to top